Maxiflo 250 Inhaler
Product Details:
-
CAS No
80474-14-2 (Fluticasone Propionate); 94749-08-3 (Salmeterol Xinafoate)
-
Grade
Medical
-
Application
Respiratory system
-
Molecular Formula
C27H30F2O6S (Fluticasone Propionate); C12H18Cl2N2O (Salmeterol Xinafoate)
-
Purity
Pharmaceutical grade
-
Formulations Type
Inhalation Therapy
-
Formulations Form
Inhaler
-
Click to View more
-
Maxiflo 250 Inhaler Product Specifications
-
250 mcg per puff
-
Respiratory system
-
Medical
-
Inhaler
-
Used for the treatment of asthma and chronic obstructive pulmonary disease (COPD)
-
Adults and adolescents aged 12 years and above
-
1 or 2 inhalations twice daily as prescribed by a healthcare professional
-
C27H30F2O6S (Fluticasone Propionate); C12H18Cl2N2O (Salmeterol Xinafoate)
-
Pharmaceutical grade
-
80474-14-2 (Fluticasone Propionate); 94749-08-3 (Salmeterol Xinafoate)
-
Store below 30C protect from direct sunlight and moisture
-
Inhalation Therapy
Other Products in 'Pharmaceutical Ointments & Creams' category
|